Stock listing
Lattice Biologics Ltd
Selected listing: LBLTF · OTC · USD · US
Lattice Biologics Ltd (OTC:LBLTF), Health Technology. Latest release May 1, 2018: BCSC Revocation of Cease Trade Order.
- Ticker
- OTC:LBLTF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Lattice Biologics Ltd
Lattice Biologics Ltd (Ticker: LBLTF) is a public company based in the United States, focusing on the development and commercialization of innovative biologic products. The company specializes in regenerative medicine, particularly in the areas of bone and tissue repair. Lattice Biologics aims to improve patient outcomes through advanced technologies and solutions in the healthcare sector.
Latest news from Lattice Biologics Ltd
BCSC Revocation of Cease Trade Order
April 30, 2018
Lattice Biologics Ltd. Announces Management Cease Trade Order
January 30, 2018
Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer
December 22, 2017
Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights
August 29, 2017
Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call
August 25, 2017
Research Lattice Biologics Ltd
Lattice Biologics Ltd company profile
View the public company page for Lattice Biologics Ltd on 6ix.
Lattice Biologics Ltd news
Read company news and market updates connected to Lattice Biologics Ltd.
Lattice Biologics Ltd investor events
Find investor webinars, events, and replay context for Lattice Biologics Ltd.